Showing results (251-260 of 296) with videos related to

Sort By:
Pageof 30
Blood Cancer Journal|August 2, 2014
Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cellsR Bam, S U Venkateshaiah, S Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
Bone Marrow Transplantation|June 5, 1998
Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?J Mehta, G Tricot, S Jagannath, et al.
Cytotherapy|September 16, 2005
Clinical-grade myeloma Ag pre-loaded DC vaccines retain potency after cryopreservationS Szmania, Q Yi, M Cottler-Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemiaH M Kantarjian, R S Walters, M J Keating, et al.
Blood|September 1, 1985
Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual malesS P Kalter, S A Riggs, F Cabanillas, et al.
Bone Marrow Transplantation|September 19, 2006
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive modelM L Grazziutti, L Dong, M H Miceli, et al.
British Journal of Haematology|November 11, 1999
High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemiaR Desikan, M Dhodapkar, D Siegel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodesT Mahfouz, M H Miceli, F Saghafifar, et al.
Blood|July 4, 2001
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patientsB Barlogie, R Desikan, P Eddlemon, et al.
Pageof 30